Pinnacle Bancorp’s Bio-Rad Laboratories Class A BIO Stock Holding History

Pinnacle Bancorp’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-10	Closed	-$2.94K	–	927
2026 Q2	$2.94K	Sell	10 -4	-29%	-$1.14K	﹤0.01%	879
2026 Q1	$3.9K	Hold	14	–	–	﹤0.01%	825
2025 Q4	$4.24K	Hold	14	–	–	﹤0.01%	806
2025 Q3	$3.92K	Sell	14 -6	-30%	-$1.63K	﹤0.01%	830
2025 Q2	$4.83K	Hold	20	–	–	﹤0.01%	800
2025 Q1	$4.87K	Hold	20	–	–	﹤0.01%	785
2024 Q4	$6.57K	Hold	20	–	–	﹤0.01%	753
2024 Q3	$6.69K	Hold	20	–	–	﹤0.01%	747
2024 Q2	$5.46K	Sell	20 -20	-50%	-$5.82K	﹤0.01%	745
2024 Q1	$13.8K	Hold	40	–	–	﹤0.01%	611
2023 Q4	$12.9K	Buy	40 +3	+8%	+$940	﹤0.01%	595
2023 Q3	$13.3K	Hold	37	–	–	﹤0.01%	574
2023 Q2	$14K	Buy	37 +9	+32%	+$3.66K	﹤0.01%	551
2023 Q1	$13.4K	Buy	28 +20	+250%	+$9.36K	﹤0.01%	560
2022 Q4	$3K	Buy	+8	New	+$3.23K	﹤0.01%	688

Other funds holding BIO

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Hosking Partners London, United Kingdom $2.81B AUM 67.07% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return

SGH

Sivik Global Healthcare Greenwich, Connecticut $175M AUM 28.78% 1-Year Est. Return

Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return

Focused Alpha LLC Denver, Colorado $402M AUM 23.92% 1-Year Est. Return

Pinnacle Bancorp's BIO Position: Q3 2026 in Review

Pinnacle Bancorp sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2026, closing a stake of 10 shares — an estimated $2.94K sold.

Pinnacle Bancorp first reported a position in BIO in Q4 2022 and held it in 15 quarters. The position peaked at $14K in Q2 2023. 69 funds tracked by Wall St. Rank hold BIO as of Q3 2026.

Pinnacle Bancorp reported no remaining Bio-Rad Laboratories Class A position as of Q3 2026 after selling out during the quarter.
Pinnacle Bancorp sold 10 Bio-Rad Laboratories Class A shares in Q3 2026, an estimated $2.94K.
Pinnacle Bancorp first reported a position in Bio-Rad Laboratories Class A in Q4 2022 and held it in 15 quarters.
Pinnacle Bancorp's Bio-Rad Laboratories Class A position peaked at $14K in Q2 2023.
69 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.

Based on Pinnacle Bancorp's 13F filing for Q3 2026, filed 21 Oct 2026.